Jefferies Starts Minerva Neurosciences (NERV) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
JMP Securities Starts Minerva Neurosciences (NERV) at Market Outperform
July 28, 2014 8:04 AM EDTJMP Securities initiated coverage on Minerva Neurosciences (NASDAQ: NERV) with a Market Outperform rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Minerva Neurosciences click here. For more ratings news on Minerva Neurosciences click here.
Shares of Minerva Neurosciences closed at $6.78 yesterday.
... MoreBaird Starts Minerva Neurosciences (NERV) at Outperform
July 28, 2014 7:31 AM EDTBaird initiates coverage on Minerva Neurosciences (NASDAQ: NERV) with a Outperform rating and a price target of $11.00.
Analyst Brian Skorney comments, "several shots on goal make Minerva an interesting opportunity, initiating at Outperform with an $11 price target. Despite the high inherent risk associated... More
